U.S. Food and Drug Administration Approves Expanded Indication of Gilead's Biktarvy® for Treatment of HIV-1 in Pediatric Populations Biotech Investing
Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx, into Brazil, Mexico, and Canada Biotech Investing
APPH, BMY, EAR, HYZN SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set Biotech Investing
AbbVie Receives CHMP Positive Opinion for Risankizumab for the Treatment of Adults with Active Psoriatic Arthritis in the European Union Biotech Investing
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis Biotech Investing
Sirona Biochem CEO: Unique Opportunity for Global Success in the Cosmetic and Therapeutic Spaces Video Interview
Gilead Sciences to Release Third Quarter 2021 Financial Results on Thursday, October 28, 2021 Biotech Investing
BioHarvest Sciences Inc. Increases Its VINIA 2021 Annual Sales Orders Forecast for Israel by 15% Biotech Investing
Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia in Patients with Relapsing Forms of Multiple Sclerosis Biotech Investing
